Literature DB >> 1066694

Interrelationship of hexosaminidases A and B: conformation of the common and the unique subunit theory.

S K Srivastava, J E Wiktorowicz, Y C Awasthi.   

Abstract

Human kidney hexosaminidase A (beta-N-acetylglucosaminidase; 2-acetamido-2-deoxy-beta-D-glucoside acetamidodeoxyglucohydrolase; EC 3.2.1.30) is a heteropolymer of two immunologically distinct subunits designated as alpha and beta. Hexosaminidase B, however, is a homopolymer comprised entirely of beta subunits. When human kidney hexosaminidase A was dissociated into its subunits by p-hydroxymercuribenzoate, three distinct proteins having isoelectric points of pH 7.2.5.4, and 4.3 were isolated. The fraction having an isoelectric point of pH 7.2, designated as beta fraction, was electrophoretically and immunologically identical to hexosaminidase B and was enzymatically active. The proteins having isoelectric points of pH 5.4 and 4.3, designated as hexosaminidase Ai and alpha fractions, respectively, were enzymatically inactive and crossreacted with antiserum against hexosaminidase A and not with antiserum against hexosaminidase B. Upon incubation of p-hydroxymercuribenzoate-treated hexosaminidase A with dithiothreitol,, hexosaminidase A activity, as well as antigenicity, was regenerated, indicating that alpha and beta subunits hybridize to form hexosaminidase A. Antibodies raised in rabbits against beta fractions reacted with both hexosaminidase A and B, whereas the antibodies against alpha and hexosaminidase Ai fractions reacted only against hexosaminidase A. This would indicate that both fractions are composed only of subunits unique to hexosaminidase A. The molecular weights of alpha,beta, and hexosaminidase Ai fractions were estimated to be 47,000, 120,000, and 180,000 respectively, by Sephadex gel filtration. Upon urea-sodium dodecyl sulfate polyacrylamide electrophoresis, each of the three fractions dissociated into a single polypeptide having a molecular weight of approximately 18,000. It is concluded that p-hydroxymercuribenzoate dissociates hexosaminidase A, (alphabeta)3, into its subunits, and the beta subunits can reassociate to form relatively stable hexosaminidase B, (betabeta)3, while the alpha subunits reassociate in both the dimeric state, alpha2, and a polymeric state, alpha8.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1066694      PMCID: PMC430766          DOI: 10.1073/pnas.73.8.2833

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase.

Authors:  A Goldstone; P Konecny; H Koenig
Journal:  FEBS Lett       Date:  1971-02-12       Impact factor: 4.124

2.  MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY.

Authors:  G K ACKERS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

3.  Isolation and relationship of human hexosaminidases.

Authors:  J F Tallman; R O Brady; J M Quirk; M Villalba; A E Gal
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

4.  Genetic complementation after fusion of Tay-Sachs and Sandhoff cells.

Authors:  G H Thomas; H A Taylor; C S Miller; J Axelman; B R Migeon
Journal:  Nature       Date:  1974-08-16       Impact factor: 49.962

5.  Conversion of human hexosaminidase A to hexosaminidase "B" by crude Vibrio cholerae neuraminidase preparations: merthiolate is the active factor.

Authors:  P J Carmody; M C Rattazzi
Journal:  Biochim Biophys Acta       Date:  1974-11-05

6.  Analytical and preparative isoelectric focusing in gel-stabilized layers.

Authors:  B J Radola
Journal:  Ann N Y Acad Sci       Date:  1973-06-15       Impact factor: 5.691

7.  Deficient hexozaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs.

Authors:  K Sandhoff; U Andreae; H Jatzkewitz
Journal:  Life Sci       Date:  1968-03-15       Impact factor: 5.037

8.  Rapid binding of PMB to non-SH groups on hemerythrin.

Authors:  M H Klapper
Journal:  Biochem Biophys Res Commun       Date:  1970-01-06       Impact factor: 3.575

9.  Human beta-D-N-acetylhexosaminidases A and B: expression and linkage relationships in somatic cell hybrids.

Authors:  P A Lalley; M C Rattazzi; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

View more
  11 in total

Review 1.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

2.  Purification and properties of human kidney-cortex hexosaminidases A and B.

Authors:  J E Wiktorowicz; Y C Awasthi; A Kurosky; S K Srivastava
Journal:  Biochem J       Date:  1977-07-01       Impact factor: 3.857

3.  Purification and properties of glutathione peroxidase from human placenta.

Authors:  Y C Awasthi; D D Dao; A K Lal; S K Srivastava
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

4.  Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.

Authors:  E Beutler
Journal:  West J Med       Date:  1977-01

5.  The multiple forms and kinetic properties of the N-acetyl-beta-D-hexosaminidases from colonic tumours and mucosa of rats treated with 1,2-dimethylhydrazine.

Authors:  N Mian; D G Herries; D M Cowen; E A Batte
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

6.  Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow.

Authors:  M Begoña Cachón-González; Susan Z Wang; Rosamund McNair; Josephine Bradley; David Lunn; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

7.  A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.

Authors:  B L Triggs-Raine; E H Mules; M M Kaback; J S Lim-Steele; C E Dowling; B R Akerman; M R Natowicz; E E Grebner; R Navon; J P Welch
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

8.  Demonstration of cross-reacting material in Tay-Sachs disease.

Authors:  S K Srivastava; N H Ansari; L A Hawkins; J E Wiktorowicz
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

9.  The effect of membrane phospholipid acyl-chain composition on the activity of brain-beta-N-acetyl-D-glucosaminidase.

Authors:  A Orlacchio; C Maffei; L Binaglia; G Porcellati
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

10.  Reversibility of neuropathology in Tay-Sachs-related diseases.

Authors:  María-Begoña Cachón-González; Susan Z Wang; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.